StonvexLoading…
StonvexStonvexStonvexCore line items from GOCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $361.85M | $798.89M | $734.67M | $631.67M |
Operating Income | $-412.90M | $-7.05M | $-81.68M | $-318.67M |
Net Income | $-257.13M | $-2.93M | $-63.26M | $-148.71M |
EPS (Diluted) | $-20.17 | $-0.66 | $-7.19 | $-17.72 |
Total Assets | $987.38M | $1.49B | $1.50B | $1.66B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $32.90M | $40.92M | $90.81M | $16.46M |
Free Cash Flow OCF − CapEx | $-130.19M | $-35.34M | $95.41M | $47.39M |
Shares Outstanding | 12.94M | 9.98M | 9.29M | 8.45M |